Status
Conditions
Treatments
About
We enroll pediatric patients who were diagnosed COVID-19 for main observation target. We will perform brain MRI and neuropsychiatric evaluation 4-6 months after COVID-19 diagnosed. We also enroll healthy age- and gender-matched participant for cross-over comparison. We will perform same evaluation process one year later for longitudinal evaluation
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
500 participants in 2 patient groups
Loading...
Central trial contact
Wang-Tso Lee, PHD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal